{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:57:37Z","timestamp":1758970657972},"reference-count":23,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mem. Inst. Oswaldo Cruz"],"DOI":"10.1590\/0074-02760140458","type":"journal-article","created":{"date-parts":[[2015,5,30]],"date-time":"2015-05-30T22:24:06Z","timestamp":1433024646000},"page":"543-550","source":"Crossref","is-referenced-by-count":6,"title":["Using a single tablet daily to treat latent tuberculosis infection in Brazil: bioequivalence of two different isoniazid formulations (300 mg and 100 mg) demonstrated by a sensitive and rapid high-performance liquid chromatography-tandem mass spectrometry method in a randomised, crossover study"],"prefix":"10.1590","volume":"110","author":[{"given":"Andr\u00e9","family":"Daher","sequence":"first","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"Pitta","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tereza","family":"Santos","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Draurio","family":"Barreira","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Pinto","sequence":"additional","affiliation":[{"name":"Minist\u00e9rio da Sa\u00fade,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2015,6,2]]},"reference":[{"key":"ref1","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","volume":"1","author":"Akolo C","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"ref2","series-title":"Resolu\u00e7\u00e3o 898. Guia para planejamento e realiza\u00e7\u00e3o da etapa estat\u00edstica de estudos de biodisponiblidade relativa\/bioequival\u00eancia","year":"2003"},{"key":"ref3","series-title":"Resolu\u00e7\u00e3o 899. Guia para valida\u00e7\u00e3o de m\u00e9todos anal\u00edticos e bioanal\u00edticos","year":"2003"},{"key":"ref4","series-title":"Instru\u00e7\u00e3o Normativa 4","year":"2011"},{"key":"ref5","first-page":"61","article-title":"The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis","volume":"79","author":"Blomberg B","year":"2001","journal-title":"Bull World Health Organ"},{"key":"ref6","first-page":"732","article-title":"Isoniazid pro- phylaxis in contacts of persons with known tuberculosis. Second report","volume":"92","author":"Bush Jr OB","year":"1965","journal-title":"Am Rev Respir Dis"},{"key":"ref7","first-page":"810","article-title":"Isoniazid prophylaxis in an undeveloped area","volume":"86","author":"Comstock GW","year":"1962","journal-title":"Am Rev Respir Dis"},{"key":"ref8","first-page":"277","article-title":"Chemoprophylaxis in the Philippines: a controlled pilot study among household contacts of tuberculosis cases","volume":"7","author":"Del Castillo H","year":"1965","journal-title":"Bull Quezon Institute"},{"key":"ref9","first-page":"419","article-title":"The use of isoniazid among household contacts of open cases of pulmonary tuberculosis","volume":"33","author":"Egsmose T","year":"1965","journal-title":"Bull World Health Organ"},{"key":"ref10","series-title":"Guidance for industry: bioanalytical method validation","year":"2001"},{"key":"ref11","series-title":"Guidance for industry: bioequivalence guidance","year":"2006"},{"key":"ref12","first-page":"509","article-title":"Epidemiological basis of tuberculosis eradication. 4. The isoniazid trial in Greenland","volume":"35","author":"Horwitz O","year":"1966","journal-title":"Bull World Health Organ"},{"key":"ref13","first-page":"555","article-title":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial","volume":"60","year":"1982","journal-title":"Bull World Health Organ"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2004.03.001","article-title":"Classification of orally administered drugs on the World Health Organization Model List of Essential Medicines according to the biopharmaceutics classification system","volume":"58","author":"Lindenberg M","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"key":"ref15","first-page":"10","article-title":"How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis","volume":"2","author":"Mitchison DA","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref16","series-title":"Recomenda\u00e7\u00f5es para terapia anti-retroviral em adultos infectados pelo HIV: 2008","year":"2008"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1043-6618(03)00175-0","article-title":"Evaluation of bioequivalence of isoniazid and pyrazinamide in three and four drugs fixed dose combinations using WHO simplified protocol","volume":"48","author":"Panchagnula R","year":"2003","journal-title":"Pharmacol Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-101-5-641","article-title":"Tuberculosis, atypical mycobacteriosis and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in south Florida","volume":"101","author":"Pitchenik AE","year":"1984","journal-title":"Ann Intern Med"},{"key":"ref19","series-title":"Manual de recomenda\u00e7\u00f5es para o controle da tuberculose no Brasil","year":"2011"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1365\/s10337-007-0391-7","article-title":"HPLC-MS analysis of isoniazid in dog plasma","volume":"66","author":"Wang A","year":"2007","journal-title":"Chromatographia"},{"key":"ref21","series-title":"Adherence to long-term therapies: evidence for action","year":"2003"},{"key":"ref22","series-title":"Global tuberculosis report","year":"2012"},{"key":"ref23","series-title":"WHO policy on collaborative TB\/HIV activities: guidelines for national programmes and other stakeholders","year":"2012"}],"container-title":["Mem\u00f3rias do Instituto Oswaldo Cruz"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/mioc\/v110n4\/0074-0276-mioc-0074-02760140458.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T00:05:29Z","timestamp":1520294729000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0074-02762015000400543&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,2]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,6]]}},"alternative-id":["S0074-02762015000400543"],"URL":"https:\/\/doi.org\/10.1590\/0074-02760140458","relation":{},"ISSN":["1678-8060","0074-0276"],"issn-type":[{"value":"1678-8060","type":"electronic"},{"value":"0074-0276","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6,2]]}}}